All News

Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.

What New York City is doing to curb the opioid epidemic.

This year's meeting highlighted the opioid epidemic and ways pharmacists can improve patient care.

This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.

DIR fees and health-care reform will lead pharmacists’ legislative concerns.

It's still early in 2017, but the FDA has been approving drugs left and right. Here's what you need to know.

Two device failures lead Mylan to recall more than 80,000 EpiPens overseas.

A pill-like device that pumps vaccine into the mouth may make syringes obsolete.

Over 55 years, 450,000 people stayed alive and 200 million people stayed well in the United States because of vaccines.

In the battle against ADEs, pharmacists are leading the way.

New board members are helping to keep our publication great.

On a recent trip to Laos, one of our editors discovered a mobile pharmacy peddling herbal medications for everything from chickenpox to lung cancer.

Anti-IBS drug Viberzi (eluxadoline) increases risk of severe pancreatitis.

California judge blocks 11 classes in suit that claims CVS charged insurers and insured patients more than uninsured patients.

FDA set a record for generics approval, but is the process still too cumbersome?

How PDMPs are helping both patients and pharmacists.

Pharmacists could become providers helping serve patients with limited healthcare access.

Sugammadex reverses vecuronium and rocuronium, two drugs used to facilitate endotracheal intubation in surgery.

The high cost of specialty drugs demands a change in Washington, according to a report.

A look at DUR alerts-why they started, where they are now, and where they need to go.

Authorities putting more pressure on supplement manufacturers.

PBMs have a business model where they pay less even while prices go up.

A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.

Community pharmacists fight against financial pressure for their survival.

Cangrealor is the first FDA-approved P2Y12 inhibitor.

How Walgreens is helping pharmacists be more involved than ever in helping cancer patients.

A look at PDMPs in PA-what they are doing and how they are helping patients.

Noctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes.